Table 1.
CD155 expression and clinicopathological characteristics.
| Clinical or pathological characteristics | Total | CD155 | P | |
|---|---|---|---|---|
| Low | High | |||
| All cases | 268 | 125 (46.6) | 143 (53.4) | |
| Sex | 0.381 | |||
| Male | 210 | 95 (45.2) | 115 (54.8) | |
| Female | 58 | 30 (51.7) | 28 (48.3) | |
| Age (years) | 0.531 | |||
| <70 | 164 | 74 (45.1) | 90 (54.9) | |
| ≥70 | 104 | 51 (49.0) | 53 (51.0) | |
| Tumor volume (cm3) | 0.003 | |||
| <5 | 186 | 98 (52.7) | 88 (47.3) | |
| ≥5 | 82 | 27 (32.9) | 55 (67.1) | |
| Tumor differentiation | 0.973 | |||
| Well | 6 | 3 (50.0) | 3 (50.0) | |
| Moderate | 121 | 57 (47.1) | 64 (52.9) | |
| Poor | 141 | 65 (46.1) | 76 (53.9) | |
| Tumor stage | 0.046 | |||
| 0 | 11 | 4 (36.4) | 7 (63.6) | |
| 1 | 32 | 21 (65.6) | 11 (34.4) | |
| 2 | 66 | 36 (54.5) | 30 (45.5) | |
| 3 | 123 | 48 (39.0) | 75 (61.0) | |
| 4 | 36 | 16 (44.4) | 20 (55.6) | |
| Tumor depth | 0.048 | |||
| T1 | 36 | 20 (55.6) | 16 (44.4) | |
| T2 | 34 | 21 (61.8) | 13 (38.2) | |
| T3 | 169 | 68 (40.2) | 101 (59.8) | |
| T4 | 29 | 16 (55.2) | 13 (44.8) | |
| Lymph node involvement | 0.002 | |||
| N0 | 85 | 45 (52.9) | 40 (47.1) | |
| N1 | 62 | 38 (61.3) | 24 (38.7) | |
| N2 | 56 | 16 (28.6) | 40 (71.4) | |
| N3 | 65 | 26 (40.0) | 39 (60.0) | |
| Metastasis | 0.439 | |||
| M0 | 238 | 113 (47.5) | 125 (52.5) | |
| M1 | 30 | 12 (40.0) | 18 (60.0) | |